FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

4074501000001101: Report only serious adverse reactions to the Committee on Safety of Medicines (qualifier value)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2004. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
10072401000001114 Report only serious adverse reactions to the Committee on Safety of Medicines en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
36829401000001111 Report only serious adverse reactions to the Committee on Safety of Medicines (qualifier value) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Report only serious adverse reactions to the Committee on Safety of Medicines Is a CSM warning status messages true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Isosorbide mononitrate 10mg+20mg tablet starter pack CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Modisal LA 25 m/r capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Elantan LA 25 capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Isib 40mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Isib 20mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Monit SR 40mg m/r tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Isosorbide mononitrate 40mg m/r tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Mono-Cedocard 10mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Ismo Retard 40mg m/r tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Isotrate 20mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Elantan 10 tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Dynamin 10mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Isotrate 40mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Isotrate 10mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Angeze 40mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Angeze 20mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Angeze 10mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Ismo 10 tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Mono-Cedocard 40mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Jeridin 20mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Imtack 1.25mg spray CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Cedocard Retard 40mg m/r tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Isoket 0.05% 25mg/50mL injection CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Isoket Retard 40 m/r tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Sorbid-20 SA m/r capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Isoket 0.1% 100mg/100mL injection CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Isoket 0.1% 50mg/50mL injection CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Isordil 5mg sublingual tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Minitran 15mg/24hours transdermal patch CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Minitran 10mg/24hours transdermal patch CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Minitran 5mg/24hours transdermal patch CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Deponit 10mg/24hours transdermal patch CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Transiderm-Nitro 10mg/24hours transdermal patch CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Transiderm-Nitro 5mg/24hours transdermal patch CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Percutol 2% ointment CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Sorbitrate 10mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Sorbichew 5mg chewable tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Angitak 1.25mg spray CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Isocard 30mg transdermal spray CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Isordil 30mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Isordil 10mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Nitrocine 10mg/10mL injection CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Nitrocine 50mg/50mL injection CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
BI-CARZEM XL 240mg m/r capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
BI-CARZEM XL 300mg m/r capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Slozem 300mg m/r capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Zildil SR 120mg m/r capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Zildil SR 90mg m/r capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Zildil SR 60mg m/r capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
BI-CARZEM SR 120mg m/r capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
BI-CARZEM SR 90mg m/r capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
BI-CARZEM SR 60mg m/r capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Dilcardia XL 240mg m/r capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Dilcardia XL 180mg m/r capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Dilcardia XL 120mg m/r capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Optil XL 300 m/r capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Optil XL 240 m/r capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Optil SR 180 m/r capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Optil SR 120 m/r capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Optil SR 90 m/r capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Zemtard 240 XL m/r capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Zemtard 180 XL m/r capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Zemtard 120 XL m/r capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Posicor 100mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Posicor 50mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Mibefradil 100mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Mibefradil 50mg tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Lercanidipine hydrochloride 10mg tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Syscor MR 30mg m/r tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Syscor MR 20mg m/r tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Syscor MR 10mg m/r tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Nisoldipine 30mg m/r tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Nisoldipine 20mg m/r tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Nisoldipine 10mg m/r tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Nifedipine 10mg capsule - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Nifedipine 5mg capsule - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Adalat Retard 10 m/r tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Adalat Retard 20 m/r tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Adalat 10mg capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Adalat 5mg capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Nicardipine hydrochloride 30mg capsule - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Nicardipine hydrochloride 20mg capsule - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Nicardipine hydrochloride 30mg m/r capsule - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Nicardipine hydrochloride 45mg m/r capsule - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Cardene SR 45mg m/r capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Cardene SR 30mg m/r capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Cardene 30mg capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Cardene 20mg capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Diltiazem hydrochloride 60mg m/r tablet - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Angitil XL 300 m/r capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Angitil XL 240 m/r capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Dilcardia SR 120mg m/r capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Dilcardia SR 90mg m/r capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Calazem 60mg m/r tablet CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Viazem XL 360mg m/r capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Diltiazem hydrochloride 360mg m/r capsule - product CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Viazem XL 300mg m/r capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Viazem XL 240mg m/r capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Viazem XL 180mg m/r capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Viazem XL 120mg m/r capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier
Zemtard 300 XL m/r capsule CSM recommendation to report adverse reactions False Report only serious adverse reactions to the Committee on Safety of Medicines Additional relationship Existential restriction modifier

Start Previous Page 77 of 118 Next End


This concept is not in any reference sets

Back to Start